Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MT-1 vs MT-2 Stability

MT-2's cyclic structure gives it a meaningful stability advantage over MT-1. The lactam bridge physically impedes proteases from accessing and cleaving certain backbone positions. In cell culture and receptor assay conditions: MT-2 demonstrates good stability

This comparison does not assign a generated winner or score.

  • MT-2's cyclic structure gives it a meaningful stability advantage over MT-1. The lactam bridge physically impedes proteases from accessing and cleaving certain backbone positions. In cell culture and receptor assay conditions:
  • MT-2 demonstrates good stability over the timescales typical of cell-based assays (hours to days)
  • MT-1, being linear, is somewhat more susceptible to proteolytic degradation, though its NDP-α-MSH modifications do provide substantially better stability than native α-MSH
  • For long-duration incubation experiments, MT-2 is generally the more reliable choice purely from a stability standpoint.
More references

Related material

Comparison

Melanotan I vs Melanotan II

Melanotan I vs Melanotan II Melanotan I and Melanotan II differ in receptor selectivity, approved-drug history, sexual effects, and safety concerns. Neither is FDA-approved as a t…

View details →
Comparison

Quick Comparison

1 Ascension Peptides50% OFF—THEPEPTIDECATALOGCopy Yes 10/10 10mg$50.00$5.00/mgView → 2 Ion Peptide15% OFF—thepeptidecatalogCopy 9.5/10 10mg$35.00$3.50/mgView → 3 EZ Peptides10% OF…

View details →
Comparison

MT-I vs MT-II

More MC1R-selective than Melanotan II, so it tans with far less of MT-II's appetite-suppression and spontaneous-erection activity — but is used more frequently.

View details →
Comparison

Pharmacokinetic Comparison

The pharmacokinetic profiles diverge as sharply as the structures. Tmax ~36 h ~1-2 h Intrinsic t1/2 ~30 min Apparent t1/2 ~15 h (implant-driven) Cmax 3.7 ng/mL Not well characteri…

View details →